On the buying side, ARK made a substantial acquisition of 338,299 shares of Figma Inc (FIG), with 289,241 shares through its ARKK ETF and 49,058 shares through its ARKW ETF, totaling $8,748,412. This ...
MarketBeat on MSN
CRISPR Therapeutics gains after earnings as pipeline hope grows
CRISPR Therapeutics AG (NASDAQ: CRSP) stock is up more than 12% after the gene editing pioneer reported its Q4 2025 earnings ...
Learn more about whether Catalyst Pharmaceuticals, Inc. or IDEAYA Biosciences, Inc. is a better investment based on AAII's A+ ...
Learn more about whether IDEAYA Biosciences, Inc. or Travere Therapeutics, Inc. is a better investment based on AAII's A+ ...
Cathie Wood's ARK Invest bought Recursion Pharmaceuticals and CRISPR Therapeutics while selling PagerDuty, Teradyne, and Salesforce on8, 2026.
CRISPR Therapeutics' CASGEVY gene-editing therapy targets severe SCD and TDT. Click here to read why CRSP stock is rated as a Buy.
CRISPR Therapeutics is commercially validated with CASGEVY but remains financially unproven and operates at a loss. Click to read this CRSP stock update.
Zacks Investment Research on MSN
CRISPR Therapeutics AG (CRSP) is attracting investor attention: Here is what you should know
CRISPR Therapeutics AG (CRSP) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to ...
Today’s Forbes Daily also covers Anthropic’s hot streak, a junk bond master, Les Wexner’s upcoming Epstein deposition, cutting edge bobsled engineering and more.
Cathie Wood's ARK Invest buys Broadcom, AMD and Coinbase while selling $13.3M of Teradyne on Feb 17, 2026. Full ETF trade breakdown.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results